Q6P988 (NOTUM_HUMAN) Homo sapiens (Human)

Palmitoleoyl-protein carboxylesterase NOTUM UniProtKBInterProSTRINGInteractive Modelling

496 aa; Sequence (Fasta)

Available Structures

123 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
STRUCTURE OF THE WNT DEACYLASE NOTUM IN COMPLEX WITH O-PALMITOLEOYL SERINE - CRYSTAL FORM IX - 1.5A Heteromer
O00755;
87-451
NAG;NA;CL;PAM;
Assess
STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM VIII - PHOSPHATE COMPLEX - 2.4Ahomo-3-mer83-451
NAG;PO4;
Assess
STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM I APO - 2.2Ahomo-2-mer86-451
CL;NAG;SO4;
Assess
STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM I HEPARIN FRAGMENT COMPLEX - 1.7Amonomer85-451
SGN;NAG;
Assess
STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM I IODIDE COMPLEX - 2.3Amonomer85-451
NAG;IOD;CL;
Assess
Structure of the Wnt deacylase Notum in complex with isoquinoline 45monomer86-451
NAG;JV8;SO4;DMS; 10×EDO;
Assess
ARUK3000263 complex with Notummonomer86-451
NAG;SO4;DMS;EDO;QR2;
Assess
STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM III - 1.4Amonomer86-451
NAG;SO4;
Assess
STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM V - SOS COMPLEX - 1.9Amonomer86-451
GU4;NAG;CL;
Assess
STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM I MYRISTOLEATE COMPLEX - 2.1Amonomer86-451
MYZ;
Assess
Notum_Ghrelin complexmonomer86-451
NAG;K4Q;
Assess
STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM VII - SOS COMPLEX - 2.2Amonomer86-451
GU4;NAG;CL;
Assess
STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM II - 2.8Amonomer87-452
Assess
Notum complex with ARUK3003910monomer87-451
NAG;SO4;DMS;SRQ;EDO;GOL;
Assess
Notum complex with ARUK3003906monomer87-451
NAG;SO4;DMS;SRH;EDO;GOL;
Assess
Theophylline-Notum complexmonomer87-451
SO4;DMS; 20×EDO;NAG;TEP;
Assess
Notum complex with ARUK3003902monomer87-451
NAG;SO4;DMS;EDO;SSQ;
Assess
Notum complex with ARUK3003775monomer87-451
SO4;DMS;EDO;SUQ;
Assess
Notum complex with ARUK3003778monomer87-451
SO4;DMS;SXQ;
Assess
Notum complex with ARUK3003776monomer87-451
SO4;DMS;EDO;STK;
Assess
Notum complex with ARUK3003718monomer87-451
NAG;SO4;DMS;EDO;SRK;
Assess
Notum complex with ARUK3003934monomer87-451
NAG;SO4;DMS;EDO;SWQ;
Assess
Notum S232A in complex with ARUK3003718monomer87-451
NAG;SO4;DMS;EDO;SRK;
Assess
Furano[2,3-d]prymidine amides as Notum inhibitorsmonomer87-451
DMS;SO4; 13×EDO;NAG;M9N;
Assess
Notum Cotininemonomer87-451
SO4;GOL;NAG;U5H;
Assess
ARUK3001043_Notummonomer87-451
NAG;EDO;SO4;FNW;DMS;
Assess
STRUCTURE OF THE WNT DEACYLASE NOTUM IN COMPLEX WITH A BENZOTRIAZOLE FRAGMENTmonomer87-451
NAG;SO4;EDO;JV5;
Assess
Notum fragment_126 (2-(1,2-dihydroacenaphthylen-5-ylsulfanyl)acetic acid)monomer87-451
SO4;GOL;NAG;U5B;
Assess
STRUCTURE OF THE WNT DEACYLASE NOTUM IN COMPLEX WITH A PYRROLE-3-CARBOXYLIC ACID FRAGMENT 454monomer87-451
SO4;PQZ;NAG;
Assess
STRUCTURE OF THE WNT DEACYLASE NOTUM IN COMPLEX WITH A PYRROLIDINE-3-CARBOXYLIC ACID FRAGMENT 587monomer87-451
SO4;EDO;PQT;NAG;
Assess
STRUCTURE OF THE WNT DEACYLASE NOTUM IN COMPLEX WITH A PYRROLE-3-CARBOXYLIC ACID FRAGMENT 686monomer87-451
PQK;NAG;SO4;EDO;
Assess
STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM IV - 2.1Amonomer87-451
NAG;CL;
Assess
STRUCTURE OF THE WNT DEACYLASE NOTUM - CRYSTAL FORM VI - 2.2Amonomer87-451
CL;
Assess
Notum fragment_1 (2-(isoquinolin-1-ylsulfanyl)acetic acid)monomer87-451
SO4;GOL;NAG;U4K;
Assess
Notum fragment_50 (3-(quinazolin-4-ylsulfanyl)propanoic acid)monomer88-451
SO4;NAG;DMS;U58;
Assess
Notum-maybridge_18monomer88-451
SO4;NAG;DMS;GOL;U2Q;
Assess
Notum_Maybridge_4monomer88-451
SO4;NAG;U2T;
Assess
1-phenylpyrroles and 1-enylpyrrolidines as inhibitors of Notummonomer88-451
NAG;SO4;DMS;EDO;PJK;
Assess
Notum Fragment_130 (4H-thieno[3,2-c]chromene-2-carboxylic acid)monomer88-451
SO4;NAG;EDO;U62;DMS;
Assess
Notum_Maybridge_56monomer88-451
SO4;NAG;DMS;GOL;U2W;
Assess
Notum ARUK3003710monomer88-451
NAG;SO4;DMS;EDO;U5T;
Assess
Notum-Fragment 110monomer88-451
SO4;NAG;AWP;EDO;
Assess
Notum complex with ARUK3002697monomer88-451
SO4;DMS;EDO;SWT;
Assess
Notum in complex with ARUK3002704monomer88-451
NAG;SO4;DMS;EDO;RW8;
Assess
Notum complex with ARUK3003907monomer88-451
SO4;DMS;SQW;
Assess
Notum complex with ARUK3003909monomer88-451
SO4;EDO;SSW;DMS;
Assess
Notum Fragment 923monomer88-451
SO4;NAG;DMS;WNA;
Assess
Notum complex with ARUK3003748monomer88-451
SO4;DMS;SUT;
Assess
Notum Fragment 297monomer88-451
SO4;NAG;DMS;T3T;
Assess
Structure of Notum in complex with a 1-(3-Chlorophenyl)-2,5-dimethyl-1H-pyrrole-3-carboxylic acid i…monomer88-451
PZ8;NAG;DMS;SO4;EDO;
Assess
N-acetylserotonin-Notum complexmonomer88-451
NAG;SO4;EDO;DMS;ASE;
Assess
Notum-Fragment065monomer88-451
SO4;NAG;EDO;JFS;DMS;
Assess
Notum_Valsartan complexmonomer88-451
SO4;NAG;EDO;U35;DMS;
Assess
Notum Fragment_130_methyEster (methyl 4H-thieno[3,2-c]chromene-2-carboxylate)monomer88-451
SO4;NAG;DMS;GOL;U65;
Assess
Furano[2,3-d]prymidine amides as Notum inhibitorsmonomer88-451
SO4;NAG;M9K;EDO;
Assess
Notum Rosmarinic acid complexmonomer88-451
SO4;NAG;EDO;ROA;
Assess
Notum-Fragment067monomer88-451
SO4;NAG;AW7; 16×EDO;
Assess
Notum Fragment_274 [(4-fluorophenyl)amino]thioureamonomer88-451
SO4;GOL;EDO;U5Z;DMS;
Assess
Notum Fragment 927monomer88-451
SO4;NAG;DMS;TEH;
Assess
Notum Fragment 872monomer88-451
SO4;NAG;DMS;QL5;
Assess
Notum-Fragment 147monomer88-451
SO4;NAG;DMS;EDO;GRV;
Assess
Notum_Piperine complexmonomer88-451
SO4;NAG;DMS;AYR;
Assess
Notum TDZD8 complexmonomer88-451
11×SO4;GOL;NAG;U3W;DMS;
Assess
Notum-Fragment 174monomer88-451
SO4;NAG;EDO;AY4;
Assess
Notum fragment 723monomer88-451
NAG;GOL; 12×SO4;DMS;JVB;
Assess
Notum Fragment 916monomer88-451
SO4;NAG;DMS;NW7;
Assess
Notum Fragment 924monomer88-451
SO4;NAG;DMS;TE8;
Assess
N-[2-(5-fluoro-1H-indol-3-yl)ethyl]acetamide-Notum complexmonomer88-451
SO4; 12×EDO;NAG;HWH;
Assess
Notum Fragment 900monomer88-451
SO4;NAG;DMS;O1J;
Assess
Notum-Bepridil complexmonomer88-451
SO4;NAG;BEP;DMS;
Assess
Notum-Fragment 193monomer88-451
SO4;NAG;EDO;GQM;
Assess
Notum-Fragment064monomer88-451
SO4;NAG;EDO;JFP;
Assess
Notum Riluzolemonomer88-451
13×SO4;NAG;DMS;657;
Assess
Notum Fragment 609monomer88-451
SO4;NAG;DMS;O3D;
Assess
Notum-Fragment 199monomer88-451
SO4;NAG;EDO;T1W;
Assess
Melatonin-Notum complexmonomer88-451
ML1;DMS;NAG;SO4;
Assess
Notum-Fragment 210monomer88-451
SO4;NAG;DMS;U3K;
Assess
Notum Fragment 714monomer88-451
SO4;NAG;DMS;T9Z;
Assess
Notum Fragment 810monomer88-451
SO4;DMS;NUM;
Assess
CFF-Notum complexmonomer88-451
12×SO4;NAG;DMS;CFF;GOL;
Assess
Notum Fragment 648monomer88-451
SO4;NAG;S4V;DMS;
Assess
Notum Fragment 282monomer88-451
SO4;NAG;EDO;EJW;
Assess
Notum-Fragment 201monomer88-451
SO4;NAG;RUY;
Assess
Notum Fragment 646monomer88-451
SO4;NAG;DMS;LO5;
Assess
Notum fragment 286monomer88-451
NAG;SO4;EDO;B1J;
Assess
Notum Fragment 955monomer88-451
SO4;NAG;DMS;TEZ;
Assess
Notum-Fragment 197monomer88-451
SO4;NAG;GOL;EDO;T2E;
Assess
Notum-Fragment 276monomer88-451
SO4;NAG;DMS;T2H;
Assess
Notum-Fragment074monomer88-451
DMS;EDO;SO4;NAG;JFV;
Assess
Notum Fragment 705monomer88-451
SO4;NAG;TB5;
Assess
Notum-Fragment 159monomer88-451
SO4;NAG;MJW;
Assess
Notum Fragment 886monomer88-451
SO4;NAG;DMS;GW1;
Assess
Notum Fragment 934monomer88-451
SO4;NAG;DMS;TEK;
Assess
Notum-Fragment 173monomer88-451
SO4;NAG;EDO;AXV;
Assess
Notum-Fragment049monomer88-451
SO4;NAG;EDO;JGA;
Assess
Notum-Fragment 154monomer88-451
SO4;NAG;EDO;RYM;
Assess
Notum-Fragment 151monomer88-451
SO4;NAG;DMS;SFY;
Assess
Notum Fragment 830monomer88-451
SO4;NAG;YI6;
Assess
Notum Fragment 863monomer88-451
SO4;NAG;DMS;JH7;
Assess
Notum Nicotinemonomer88-451
GOL;SO4;NAG;NCT;
Assess
Notum Fragment 772monomer88-451
SO4;NAG;T9Q;
Assess
Notum Fragment 791monomer88-451
SO4;T9B;
Assess
Notum Fragment 690monomer88-451
SO4;NAG;DMS;UR4;
Assess
Notum-Fragment 277monomer88-451
SO4;NAG;DMS;A6Z;
Assess
Notum Fragment 658monomer88-451
SO4;NAG;EDO;TAH;
Assess
Notum-Fragment 163monomer88-451
SO4;NAG;BP4;
Assess
Notum fragment_3 (4H,5H-naphtho[1,2-b]thiophene-2-carboxylic acid)monomer88-451
NAG;SO4;U4T;
Assess
Notum Fragment 828monomer88-451
SO4;NAG;JHJ;
Assess
Notum Fragment 283monomer88-451
SO4;NAG;B1A;DMS;
Assess
Notum PPOH complexmonomer88-451
SO4;NAG;DMS;GOL;U3T;
Assess
Notum-Fragment077monomer88-451
SO4;NAG;T1Z; 11×EDO;
Assess
Notum Fragment 792monomer88-451
SO4;NAG;DMS;T9K;
Assess
Notum Fragment 722monomer88-451
SO4;NAG;T9W;
Assess
Notum fragment 5emonomer88-451
SO4;NAG;DMS;U3Q;
Assess
Notum Fragment 823monomer88-451
SO4;NAG;TE5;
Assess
STRUCTURE OF THE WNT DEACYLASE NOTUM IN COMPLEX WITH A PYRROLE-3-CARBOXYLIC ACID FRAGMENT 471monomer88-451
16×SO4;DMS;PQH;NAG;
Assess
Notum_Fragment41 (N-methyl-4,5-dihydronaphtho,2-bthiophene-2-carboxamide)monomer88-451
NAG;SO4;GOL;U5E;
Assess
STRUCTURE OF THE WNT DEACYLASE NOTUM IN COMPLEX WITH A PYRROLIDINE-3-CARBOXYLIC ACID FRAGMENT 598monomer88-451
NAG;PUE;SO4;EDO;
Assess
Notum-Fragment063monomer88-451
SO4;NAG;EDO;WKA;
Assess
Notum Fragment 588monomer89-451
SO4;NAG;DMS;N9J;
Assess
Notum Fragment 290monomer88-450
SO4;NAG;T3N;
Assess
Notum Fragment 634monomer89-451
SO4;NAG;DMS;S1V;
Assess
Notum Fragment 784monomer88-450
SO4;NAG;GVV;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
4wbh.1.Ahomo-2-mer0.8686-451
100.00
Assess